SMTL ID : 6ljw.1

Crystal structure of human FABP4 in complex with a novel inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

monomer

Ligands

1 x EHO: 2-phenylazanylbenzoic acid(Non-covalent)

EHO.1: 13 residues within 4Å: Chain A: F.37, M.41, V.46, A.54, A.57, P.59, S.74, S.76, F.78, T.81, A.96, D.97, R.99 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.37, A:V.46, A:A.57, A:P.59, A:A.96, A:D.97 Hydrogen bonds: A:S.74, A:S.74, A:T.81 Water bridges: A:A.96 pi-Stacking: A:F.37, A:F.78

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 5 residues within 4Å: Chain A: I.72, T.81, E.82, I.83, R.127 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.81, A:R.127 Water bridges: A:T.81, A:E.93, A:R.127

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Su, H. et al., Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. J.Med.Chem. (2020)

Release Date

2020-04-15

Peptides

Fatty acid-binding protein, adipocyte: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fatty acid-binding protein, adipocyte

Related Entries With Identical Sequence